Evidence map›Paper›PMID 21556304›Full record

SynthesisBulletin of the World Health Organization2011

Comparative effectiveness, safety and acceptability of medical abortion at home and in a clinic: a systematic review.

Thoai D Ngo, Min Hae Park, Haleema Shakur, Caroline Free

Registry-linked trialAbstract readSystematic Review
In one paragraph

Synthesis in Bulletin of the World Health Organization, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02745093 (The Effectiveness, Safety, and Acceptability of Home-administered Medical Abortion at Gestational Age of 8 to ≤9 Weeks Versus >9 to ≤12 Weeks), which is not on this map. Cited by 53 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 10 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02745093 phase4unknown statusnot on this mapstarted 2016, after this paper: background citation

The Effectiveness, Safety, and Acceptability of Home-administered Medical Abortion at Gestational Age of 8 to ≤9 Weeks Versus >9 to ≤12 Weeks: A Prospective Cohort Study in Mexico City

TypeinterventionalSponsorIbis Reproductive HealthRan2016 to 2016Enrolled648ConditionsMedical AbortionArmsMifepristone, Misoprostol
3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 10 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pain management for medical abortion before 14 weeks' gestation.The Cochrane database of systematic reviews · 2022
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Self-administered versus provider-administered medical abortion.The Cochrane database of systematic reviews · 2020
    Pooled it
  7. Telemedicine for medical abortion: a systematic review.BJOG : an international journal of obstetrics and gynaecology · 2019
    Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Thoai D NgoDepartment of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, England, UK. Thoai.Ngo@lshtm.ac.uk
Min Hae Park
Haleema Shakur
Caroline Free

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo compare medical abortion practised at home and in clinics in terms of effectiveness, safety and acceptability.

methodsA systematic search for randomized controlled trials and prospective cohort studies comparing home-based and clinic-based medical abortion was conducted. The Cochrane Central Register of Controlled Trials, EMBASE, MEDLINE and Popline were searched. Failure to abort completely, side-effects and acceptability were the main outcomes of interest. Odds ratios and their 95% confidence intervals (CIs) were calculated. Estimates were pooled using a random-effects model.

findingsNine studies met the inclusion criteria (n = 4522 participants). All were prospective cohort studies that used mifepristone and misoprostol to induce abortion. Complete abortion was achieved by 86-97% of the women who underwent home-based abortion (n = 3478) and by 80-99% of those who underwent clinic-based abortion (n = 1044). Pooled analyses from all studies revealed no difference in complete abortion rates between groups (odds ratio = 0.8; 95% CI: 0.5-1.5). Serious complications from abortion were rare. Pain and vomiting lasted 0.3 days longer among women who took misoprostol at home rather than in clinic. Women who chose home-based medical abortion were more likely to be satisfied, to choose the method again and to recommend it to a friend than women who opted for medical abortion in a clinic.

conclusionHome-based abortion is safe under the conditions in place in the included studies. Prospective cohort studies have shown no differences in effectiveness or acceptability between home-based and clinic-based medical abortion across countries.

Indexed as

Ambulatory Care FacilitiesHome Care ServicesAbortifacient Agents, SteroidalAbortion, InducedAdolescentAdultComparative Effectiveness ResearchDrug Therapy, CombinationFemaleHumansMiddle AgedMifepristoneMisoprostolPatient SatisfactionPregnancyProspective StudiesAbortifacient Agents, SteroidalMifepristoneMisoprostol

Identifiers

PMID21556304
PMCPMC3089386

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.